Rheumatology Department, Tondela Viseu Hospital Centre, 3504-509 Viseu, Portugal.
Rheumatology Department, Baixo Vouga Hospital Centre, 3810-164 Aveiro, Portugal.
Int J Environ Res Public Health. 2023 Nov 14;20(22):7062. doi: 10.3390/ijerph20227062.
The Health Assessment Questionnaire Disability Index (HAQ-DI) was completed with five visual analog scales to assess systemic sclerosis (SSc) called Scleroderma HAQ (SHAQ). We performed a validation of the European Portuguese version of SHAQ for patients with SSc. Patients with different forms of SSc from five Hospital Centers were invited. The reliability of the Portuguese SHAQ was evaluated by internal consistency and by test-retest reliability. Content validity was checked by two rheumatologists and by a panel of patients. Construct validity was assessed by structural validity and by known-groups hypothesis tests. Criterion validity was addressed with selected dimensions from the UCLA GIT 2.0, the SF-36v2, and the EuroQoL EQ-5D-5L. A total of 102 SSc patients agreed to participate, 31 of which answered to the retest. HAQ-DI demonstrated high internal consistency reliability (α = 0.866) and SHAQ also showed high test-retest reliability (ICC 0.61-0.95). We evidenced the unidimensionality of all VASs. HAQ-DI scores were worse in males, patients older than 65 years, and individuals with a diffuse form of SSc. Criterion validity was mainly evidenced through the correlation between the HAQ-DI and SF-36v2 physical summary measure (r = -0.688) and EQ-5D-5L index score (r = -0.723). Likewise, the SHAQ overall disease severity VAS was also correlated with SF-36v2 physical summary measure (r = -0.628). Mental score correlations were smaller. With the exception of the Raynaud's VAS, all the other VASs correlated well with similar clinical variables. This paper provides evidence to demonstrate how reliable and valid the European Portuguese version of SHAQ is, to be used in SSc patients to assess the clinical severity under the perspective of patients.
健康评估问卷残疾指数(HAQ-DI)采用 5 个视觉模拟量表进行评估,用于评估系统性硬化症(SSc),称为硬皮病 HAQ(SHAQ)。我们对 SSc 患者的 SHAQ 进行了验证。邀请了来自五个医院中心的不同形式的 SSc 患者。通过内部一致性和重测信度评估葡萄牙语 SHAQ 的可靠性。由两名风湿病学家和一组患者检查内容效度。结构有效性通过结构有效性和已知组假设检验进行评估。通过从 UCLA GIT 2.0、SF-36v2 和 EuroQoL EQ-5D-5L 中选择的维度评估标准效度。共有 102 名 SSc 患者同意参加,其中 31 名患者回答了重测。HAQ-DI 显示出较高的内部一致性可靠性(α=0.866),SHAQ 也显示出较高的重测信度(ICC 0.61-0.95)。我们证明了所有 VAS 的单维性。HAQ-DI 评分在男性、年龄大于 65 岁和弥漫性 SSc 患者中较差。标准效度主要通过与 SF-36v2 身体总评量表(r=-0.688)和 EQ-5D-5L 指数评分(r=-0.723)之间的相关性来证明。同样,SHAQ 整体疾病严重程度 VAS 也与 SF-36v2 身体总评量表相关(r=-0.628)。心理评分的相关性较小。除了雷诺现象 VAS 外,其他所有 VAS 与相似的临床变量相关性良好。本文提供了证据,证明了 SHAQ 欧洲葡萄牙语版本的可靠性和有效性,可用于 SSc 患者评估患者视角下的临床严重程度。